After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

IMPROVE-HIV proposal submitted to EDCTP3 to address HIV, HBV and schistosomiasis co-infections in sub-Saharan Africa

R-Evolution WorldWide, has recently submitted the project proposal IMPROVE-HIV under the European & Developing Countries Clinical Trials Partnership (EDCTP) call HORIZON-JU-GH-EDCTP3-2026-01-HIV-03-two-stage – Global collaboration action towards better prevention, treatment and clinical management

Read More

R-Evolution Worldwide is glad to announce the launch of a collaboration with the University of Salento, (the local University, in southern Italy) and with the University of Sciences, Techniques and

Read More

INTEGRATION Annual Project Meeting Y3

The INTEGRATION consortium held its annual meeting of the third year of the project on 21st and 22nd March 2024 in Paris. The INTEGRATION project involves the University of Sciences, Techniques

Read More